These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23098141)

  • 21. Coronary Microvascular Dysfunction in HIV: A Review.
    Rethy L; Feinstein MJ; Sinha A; Achenbach C; Shah SJ
    J Am Heart Assoc; 2020 Jan; 9(1):e014018. PubMed ID: 31852423
    [No Abstract]   [Full Text] [Related]  

  • 22. Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.
    Lin E; Freedman JE; Beaulieu LM
    Cardiovasc Ther; 2009; 27(2):117-23. PubMed ID: 19426249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine in coronary disease: another renaissance of an ancient drug.
    Fiolet ATL; Thompson PL; Mosterd A
    Cardiovasc Res; 2021 Jan; 117(1):e4-e6. PubMed ID: 33426561
    [No Abstract]   [Full Text] [Related]  

  • 24. Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications.
    Corinaldesi C; Di Luigi L; Lenzi A; Crescioli C
    J Endocrinol Invest; 2016 Feb; 39(2):143-51. PubMed ID: 26122487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ivabradine and endothelium: an update.
    Dallapellegrina L; Sciatti E; Vizzardi E
    Ther Adv Cardiovasc Dis; 2020; 14():1753944720934937. PubMed ID: 32611276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of the vasculature: pharmacological targets in vascular disease.
    Sobrevia L
    Curr Vasc Pharmacol; 2009 Oct; 7(4):423-5. PubMed ID: 19863478
    [No Abstract]   [Full Text] [Related]  

  • 28. Repurposing Metformin for Cardiovascular Disease.
    Rena G; Lang CC
    Circulation; 2018 Jan; 137(5):422-424. PubMed ID: 29378754
    [No Abstract]   [Full Text] [Related]  

  • 29. Autophagy in cardiovascular biology.
    Lavandero S; Chiong M; Rothermel BA; Hill JA
    J Clin Invest; 2015 Jan; 125(1):55-64. PubMed ID: 25654551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cardiovascular effects of hyperthyroidism.
    Nabbout LA; Robbins RJ
    Methodist Debakey Cardiovasc J; 2010; 6(2):3-8. PubMed ID: 20661186
    [No Abstract]   [Full Text] [Related]  

  • 31. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities.
    Le Brocq M; Leslie SJ; Milliken P; Megson IL
    Antioxid Redox Signal; 2008 Sep; 10(9):1631-74. PubMed ID: 18598143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnane X receptor polymorphism affects CYP3A4 induction via a ligand-dependent interaction with steroid receptor coactivator-1.
    Lim YP; Huang JD
    Pharmacogenet Genomics; 2007 May; 17(5):369-82. PubMed ID: 17429319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.
    Xu S; Ilyas I; Little PJ; Li H; Kamato D; Zheng X; Luo S; Li Z; Liu P; Han J; Harding IC; Ebong EE; Cameron SJ; Stewart AG; Weng J
    Pharmacol Rev; 2021 Jul; 73(3):924-967. PubMed ID: 34088867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
    França CN; Izar MCO; Hortêncio MNS; do Amaral JB; Ferreira CES; Tuleta ID; Fonseca FAH
    Clin Sci (Lond); 2017 Jun; 131(12):1215-1224. PubMed ID: 28566450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease.
    Fu P; Yang L; Sun Y; Ye L; Cao Z; Tang K
    BMC Bioinformatics; 2014; 15 Suppl 4(Suppl 4):S3. PubMed ID: 25104437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
    Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
    J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perivascular fat, AMP-activated protein kinase and vascular diseases.
    Almabrouk TA; Ewart MA; Salt IP; Kennedy S
    Br J Pharmacol; 2014 Feb; 171(3):595-617. PubMed ID: 24490856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial dysfunction and cardiovascular disease--the lull before the storm.
    Marx N; Grant PJ
    Diab Vasc Dis Res; 2007 Jun; 4(2):82-3. PubMed ID: 17654440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.